Key Details
The Allotment Committee of the Board of Directors approved the allotment of 8,781 equity shares of face value ₹2 each to grantees who exercised options under the Sudarshan Employee Stock Option Plan 2018. The meeting was held on 28th August, 2026, commencing at 11:30 AM IST and concluding at 11:45 AM IST.
Regulatory Compliance Statement (per Regulation 10(c) of SEBI Share Based Employee Benefits Regulations, 2021)
- Company Name and Registered Office: Sudarshan Chemical Industries Limited, 7th Floor, Eleven West Panchshil, Survey No. 25, Near PAN Card Club Road, Baner, Pune 411 069
- Stock Exchanges: BSE Limited and National Stock Exchange of India Limited
- Previous Filing Date: Statement under Regulation 10(b) for the ESOP plan was filed with both exchanges on 28th August, 2024
- Scheme Approval References:
- BSE In-principle approval letter no. DSC/IPO/AK/ESOP-IP/3375/2024-25 dated 24th October, 2024
- NSE In-principle approval letter no. NSE/List/43661 dated 24th October, 2024
- Scheme Title: Sudarshan Employee Stock Option Plan 2018
- Security Type: Equity Shares
- Par Value: ₹2 per share
- Distinctive Numbers: 79607577 to 79616357
- Exercise Price: ₹349.35 per share
- Premium per Share: ₹347.35
- Total Issued Shares After Issue: 7,96,16,857 shares
- Total Subscribed Shares After Issue: 7,96,16,357 shares*
- Total Issued Share Capital After Issue: ₹15,92,33,714
- Total Subscribed Capital After Issue: ₹15,92,32,714*
- Lock-in Details: Not Applicable
- Share Characteristics: The new shares rank pari passu and are identical to existing equity shares
*Note: A difference of 500 shares exists between issued capital and subscribed/paid-up capital due to allotment of 500 Right shares of ₹2 each kept in abeyance, with the matter being sub-judice.